GLAXO OPERATIONS UK LIMITED
Get an alert when GLAXO OPERATIONS UK LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-05-04 (in 1y)
Last made up 2026-04-20
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£1B
+1.4% vs 2023
Employees
3,296
+2.6% vs 2023
Profit before tax
£31M
+49.7% vs 2023
Name history
Renamed 1 time since incorporation
- GLAXO OPERATIONS UK LIMITED 1978-12-31 → present
- GLAXO LABORATORIES LIMITED 1962-01-01 → 1978-12-31
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £659,082,000 | £825,617,000 | |
| Operating profit | £28,427,000 | £39,933,000 | |
| Profit before tax | £20,666,000 | £30,938,000 | |
| Net profit | £7,131,000 | £13,877,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £1,028,178,000 | £1,040,664,000 | |
| Net assets | £1,014,273,000 | £1,028,150,000 | |
| Equity | £1,014,273,000 | £1,028,150,000 | |
| Average employees | 3,214 | 3,296 | |
| Wages | £279,770,000 | £285,390,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 4.3% | 4.8% | |
| Net margin | 1.1% | 1.7% | |
| Return on capital employed | 2.8% | 3.8% | |
| Gearing (liabilities / total assets) | 31.6% | 35.2% | |
| Current ratio | 0.52x | 0.57x | |
| Interest cover | 2.90x | 3.01x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Deloitte LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have taken into account that as part of the Group, the Company has already received the necessary letter of support from GlaxoSmithKline Finance plc and can take actions to ensure business continuity through operational channels, as well as the ability to manage variable costs. On the basis of those considerations, the Directors believe that it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “Turnover was £825,617,000 for the year ended 31 December 2024 (2023: £659,082,000). The increase is mainly due to an increase in tolling charge income, restructuring cost income and other site manufacturing income during the year. Operating profit for the year ended 31 December 2024 was £39,933,000 (2023: £28,427,000). The Company made a profit for the financial year of £13,877,000 (2023: £7,131,000). The increase in profit is mainly due to a significant increase in turnover during the year.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 43 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 1998-12-18 | — | British |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2006-08-31 | — | — |
| OLIINYK, Dmytro | Director | 2022-02-19 | Jun 1983 | Ukrainian |
| SPEAR, Paul Andrew | Director | 2020-08-25 | Jun 1974 | British |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2024-07-08 | — | — |
Show 43 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BICKNELL, Simon Michael | Secretary | 1994-11-24 | 1998-12-18 |
| CHRISTIAN, Christopher Lindsay | Secretary | — | 1994-11-24 |
| STEPHENS, Richard James | Secretary | 2003-07-21 | 2007-03-05 |
| ADCOCK, Matthew Creighton | Director | 2013-04-09 | 2014-07-01 |
| BAKER, Christopher, Dr | Director | — | 1993-05-23 |
| BAXTER, Jeffrey Royston | Director | 1997-05-02 | 2001-12-19 |
| BELL, Alan Menzies, Dr | Director | 1999-01-01 | 2001-12-30 |
| BLAKER, Graham Joseph, Dr | Director | — | 1998-06-01 |
| BRUCE, Paul Lawrence | Director | 1997-09-15 | 1998-12-18 |
| BURNS, Alan George | Director | 2017-05-05 | 2019-05-08 |
| CALDWELL, Joseph, Dr | Director | 1997-01-20 | 1998-08-19 |
| CALLIANO, Riccardo | Director | 2014-07-21 | 2017-10-01 |
| CARDWELL, Ian | Director | 2010-02-23 | 2011-12-31 |
| CARTMELL, Simon Christopher | Director | 1993-06-01 | 1995-01-01 |
| CHALLONER, Stanley Clive | Director | — | 1994-01-31 |
| ELLIOT, John Bell | Director | 2003-05-14 | 2006-12-31 |
| HEPBURN, Stuart | Director | 2012-01-04 | 2016-05-01 |
| HIGHAM, John Stanley | Director | — | 1993-03-03 |
| HUMER, Franz Bernhard | Director | — | 1993-05-12 |
| JONES, David John | Director | 2003-05-14 | 2009-05-07 |
| JONGEN, Freek | Director | 2017-10-01 | 2020-08-25 |
| JORDAN, Stephen | Director | 2003-05-14 | 2010-02-23 |
| KELLER, Philip Henry | Director | 1997-08-02 | 1997-09-12 |
| KENNEDY, James | Director | — | 1993-02-01 |
| LATCHFORD, Richard John | Director | 2021-05-07 | 2022-02-19 |
| MCCUBBIN, Ian | Director | 2013-07-05 | 2017-03-31 |
| MCINNES, Ian Alexander Thomson, Dr | Director | 1993-03-03 | 1996-10-11 |
| MILLER, Timothy John | Director | 1999-01-01 | 2000-06-02 |
| MULLINS, Sheila | Director | 2019-03-22 | 2020-08-25 |
| O'HARA, Neil | Director | 2010-02-23 | 2013-04-09 |
| PADFIELD, John Malcolm, Doctor | Director | — | 1994-03-31 |
| PARKES, Philip Edward | Director | — | 1993-08-31 |
| PATTESON-BRENT, Erika | Director | 2020-08-25 | 2021-09-29 |
| POWER, Joseph James | Director | 2019-03-22 | 2020-12-31 |
| PRICE, Barry John, Dr | Director | 1995-01-01 | 1995-12-31 |
| PULMAN, David, Doctor | Director | 1997-01-24 | 2003-05-14 |
| READSHAW, Ashley | Director | 1993-09-01 | 1997-01-17 |
| REYNAUD, Jean Paul | Director | 2003-05-14 | 2013-07-12 |
| SIMARD, Regis Jean-Pierre | Director | 2016-05-18 | 2019-05-02 |
| TYSON, Timothy Cyril | Director | 1998-06-01 | 2002-12-01 |
| VITTY, Graham John | Director | — | 1994-11-03 |
| WAIGHTS, Christopher Charles Bolingbroke | Director | 1994-04-13 | 1995-01-01 |
| GLAXO GROUP LIMITED | Corporate Director | 2002-09-11 | 2003-07-21 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxo Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 267 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-02-20 RESOLUTIONS Resolution
- 2024-02-20 MA Memorandum articles
- 2024-02-15 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-08-15 | AA | accounts | Accounts with accounts type full | |
| 2025-08-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-23 | CH03 | officers | Change person secretary company with change date | |
| 2024-09-22 | AA | accounts | Accounts with accounts type full | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-17 | CH01 | officers | Change person director company with change date | |
| 2024-09-11 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-08-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-18 | AD02 | address | Change sail address company with old address new address | |
| 2024-07-08 | AP02 | officers | Appoint corporate director company with name date | |
| 2024-02-20 | RESOLUTIONS | resolution | Resolution | |
| 2024-02-20 | MA | incorporation | Memorandum articles | |
| 2024-02-15 | CC04 | change-of-constitution | Statement of companys objects | |
| 2023-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-08-16 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-16 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-10-13 | AA | accounts | Accounts with accounts type full | |
| 2022-08-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-03-10 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+25.3%
£659,082,000 £825,617,000
-
Cash
—
Not reported
-
Net assets
+1.4%
£1,014,273,000 £1,028,150,000
-
Employees
+2.6%
3,214 3,296
-
Operating profit
+40.5%
£28,427,000 £39,933,000
-
Profit before tax
+49.7%
£20,666,000 £30,938,000
-
Wages
+2%
£279,770,000 £285,390,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers